Womenwellness

1. Womenwellness improves chair-stand test in humans (β = 1.57, 95 % CI = 0.51-2.63, p = .004).

   “reduced chair stand times (β = 1.57, 95 % CI = 0.51-2.63, p = .004)”

   Human trial12-weekfemalesn = 176

   Preserving intrinsic capacity in midlife women: A mixed-methods study of a personalized multicomponent intervention aligned with the WHO ICOPE framework

   Experimental gerontology·21 Nov 2025

More on Chair-stand test

1. Womenwellness improves intrinsic capacity composite score in humans (β = 0.39, 95 % CI = 0.03-0.75, p = .032).

   “Participants (mean age 61.5 ± 3.6 years) receiving WomenWellness showed significantly greater reductions in IC composite scores than controls (β = 0.39, 95 % CI = 0.03-0.75, p = .032)”

   Human trial12-weekfemalesn = 176

   Preserving intrinsic capacity in midlife women: A mixed-methods study of a personalized multicomponent intervention aligned with the WHO ICOPE framework

   Experimental gerontology·21 Nov 2025

More on Intrinsic capacity composite score

1. Womenwellness lowers the risk of visual impairment in humans (OR = 0.28, 95 % CI = 0.12-0.65, p = .003).

   “reduced visual impairment (OR = 0.28, 95 % CI = 0.12-0.65, p = .003)”

   Human trial12-weekfemalesn = 176

   Preserving intrinsic capacity in midlife women: A mixed-methods study of a personalized multicomponent intervention aligned with the WHO ICOPE framework

   Experimental gerontology·21 Nov 2025

More on Visual impairment

1. Womenwellness lowers the risk of malnutrition in humans (OR = 0.26, 95 % CI = 0.08-0.84, p = .025).

   “lower malnutrition risk (OR = 0.26, 95 % CI = 0.08-0.84, p = .025)”

   Human trial12-weekfemalesn = 176

   Preserving intrinsic capacity in midlife women: A mixed-methods study of a personalized multicomponent intervention aligned with the WHO ICOPE framework

   Experimental gerontology·21 Nov 2025

More on Malnutrition